Title:
細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法
Document Type and Number:
Japanese Patent JP2005505519
Kind Code:
A
Abstract:
Cytoprotective compounds, many of which are phenolic derivatives characterized by a substituted phenol having certain conjugated bonds, are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative damage. They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions.
More Like This:
| JP2005314392 | HAIR COSMETIC |
| JPS59130208 | COSMETIC COMPOSITION |
Inventors:
One, bin
Zhang, Yang-Kang
Shen, Jean
Zan, Way
Song, Jungao
Del Barzo, Ugata
Brown, leslie
Mirror, guy
Zhang, Yang-Kang
Shen, Jean
Zan, Way
Song, Jungao
Del Barzo, Ugata
Brown, leslie
Mirror, guy
Application Number:
JP2003515200A
Publication Date:
February 24, 2005
Filing Date:
July 23, 2002
Export Citation:
Assignee:
Galileo Pharmaceuticals, Inc.
International Classes:
A61K8/00; A61K8/30; A61K31/05; A61K31/055; A61K31/06; A61K31/085; A61K31/09; A61K31/10; A61K31/122; A61K31/15; A61K31/166; A61K31/18; A61K31/192; A61K31/21; A61K31/235; A61K31/277; A61K31/28; A61K31/30; A61K31/315; A61K31/343; A61K31/353; A61K31/36; A61K31/381; A61K31/4164; A61K31/4184; A61K31/426; A61K31/4425; A61K31/444; A61K31/4453; A61K31/5375; A61K31/555; A61K31/662; A61K31/7024; A61K33/32; A61P1/04; A61P3/10; A61P5/24; A61P9/00; A61P9/04; A61P9/10; A61P11/00; A61P11/06; A61P13/12; A61P15/00; A61P17/00; A61P17/02; A61P17/06; A61P17/10; A61P17/16; A61P19/02; A61P21/00; A61P25/00; A61P25/02; A61P25/16; A61P25/18; A61P25/28; A61P27/02; A61P29/00; A61P37/06; A61P43/00; A61Q19/00; A61Q19/02; C07C39/21; C07C39/373; C07C39/44; C07C43/215; C07C43/23; C07C45/30; C07C45/71; C07C49/737; C07C49/747; C07C50/34; C07C69/007; C07C69/76; C07C69/94; C07C205/17; C07C205/20; C07C205/22; C07C205/35; C07C205/57; C07C235/42; C07C255/15; C07C255/36; C07C255/53; C07C255/54; C07C311/29; C07C317/22; C07D213/30; C07D213/53; C07D231/22; C07D231/26; C07D233/24; C07D233/64; C07D235/08; C07D277/20; C07D277/24; C07D277/30; C07D277/34; C07D295/22; C07D295/18; C07D295/26; C07D307/83; C07D311/72; C07D317/62; C07D333/16; C07F1/08; C07F9/40; C07H13/08; (IPC1-7): A61K31/05; A61K7/00; A61K7/48; A61K31/055; A61K31/06; A61K31/085; A61K31/09; A61K31/10; A61K31/122; A61K31/15; A61K31/166; A61K31/18; A61K31/192; A61K31/21; A61K31/235; A61K31/277; A61K31/28; A61K31/30; A61K31/315; A61K31/343; A61K31/353; A61K31/36; A61K31/381; A61K31/4152; A61K31/4164; A61K31/4184; A61K31/426; A61K31/4425; A61K31/444; A61K31/4453; A61K31/5375; A61K31/555; A61K31/662; A61K31/7024; A61K33/32; A61P1/04; A61P3/10; A61P5/24; A61P9/00; A61P9/04; A61P9/10; A61P11/00; A61P11/06; A61P13/12; A61P15/00; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P19/02; A61P21/00; A61P25/00; A61P25/02; A61P25/16; A61P25/18; A61P25/28; A61P27/02; A61P29/00; A61P37/06; A61P43/00; C07C39/21; C07C39/373; C07C39/44; C07C43/215; C07C49/747; C07C50/34; C07C69/007; C07C69/76; C07C69/94; C07C205/17; C07C205/20; C07C205/35; C07C235/42; C07C255/15; C07C255/53; C07C255/54; C07C317/22; C07D213/30; C07D213/53; C07D231/22; C07D231/26; C07D233/24; C07D233/64; C07D235/08; C07D277/20; C07D277/24; C07D277/30; C07D277/34; C07D295/18; C07D295/22; C07D307/83; C07D311/72; C07D317/62; C07D333/16; C07F1/08; C07F3/06; C07F9/40; C07H13/08
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita
Previous Patent: ＧＡＢＡＡ受容体リガンドとしての、ヘテロアリール置換縮合二環式ヘテ...
Next Patent: 予防または治療ワクチン接種および／或いはその他疾患の治療を目的とす...
Next Patent: 予防または治療ワクチン接種および／或いはその他疾患の治療を目的とす...